Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
TOP-subsidie voor onderzoek naar vroege hersenafwijkingen Alzheimer
feb 2019 | Dementie